Stay updated on Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page displays the study record for the completed sitravatinib and nivolumab kidney cancer trial, including its eligibility criteria, study design, outcomes, and posted results.
    Difference
    55%
    Check dated 2026-11-08T01:11:47.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T19:23:30.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the page’s 403 error.
    Difference
    1%
    Check dated 2026-10-24T22:27:39.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T22:33:19.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-10T22:21:28.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden markup and the Home label from the page’s HTML, affecting only the error/navigation elements rather than the visible study content. The core study details remain unchanged.
    Difference
    0.5%
    Check dated 2026-09-26T22:06:35.000Z thumbnail image

Stay in the know with updates to Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.